A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 22,657 shares of EW stock, worth $1.66 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
22,657
Previous 21,833 3.77%
Holding current value
$1.66 Million
Previous $2.02 Million 25.84%
% of portfolio
0.58%
Previous 0.83%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$59.7 - $93.78 $49,192 - $77,274
824 Added 3.77%
22,657 $1.5 Million
Q2 2024

Jul 17, 2024

BUY
$84.3 - $94.31 $117,767 - $131,751
1,397 Added 6.84%
21,833 $2.02 Million
Q1 2024

May 02, 2024

BUY
$72.54 - $95.56 $117,442 - $154,711
1,619 Added 8.6%
20,436 $1.95 Million
Q4 2023

Jan 24, 2024

BUY
$61.71 - $77.76 $157,669 - $198,676
2,555 Added 15.71%
18,817 $1.43 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $175,555 - $236,624
2,534 Added 18.46%
16,262 $1.13 Million
Q2 2023

Jul 24, 2023

BUY
$81.41 - $94.33 $76,118 - $88,198
935 Added 7.31%
13,728 $1.29 Million
Q1 2023

Apr 19, 2023

BUY
$74.26 - $84.51 $74,260 - $84,510
1,000 Added 8.48%
12,793 $1.06 Million
Q4 2022

Jan 30, 2023

BUY
$68.3 - $87.44 $68,983 - $88,314
1,010 Added 9.37%
11,793 $879,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $34,513 - $44,954
419 Added 4.04%
10,783 $921,000
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $8,996 - $13,340
104 Added 1.01%
10,364 $998,000
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $81,262 - $102,286
797 Added 8.42%
10,260 $1.03 Million
Q4 2021

Mar 10, 2022

BUY
$106.37 - $130.68 $1.01 Million - $1.24 Million
9,463 New
9,463 $1.07 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Comprehensive Financial Consultants Institutional, Inc. Portfolio

Follow Comprehensive Financial Consultants Institutional, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.